Here's the live share price of Everest Organics along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Everest Organics has gained 8.12% CAGR. Over the past year, the corresponding return has been 195.17%.
Everest Organics’s current P/E of 64.62x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Everest Organics | 1.88 | 12.60 | 13.01 | 64.34 | 195.17 | 42.24 | 8.12 |
Sun Pharmaceutical Industries | 1.67 | -0.74 | -1.73 | -5.03 | -13.17 | 22.82 | 25.92 |
Divi's Laboratories | 0.43 | -1.79 | -7.35 | 6.82 | 11.03 | 18.72 | 13.53 |
Cipla | -0.28 | -0.33 | 3.71 | 4.44 | -6.69 | 14.64 | 15.70 |
Torrent Pharmaceuticals | -1.10 | -2.72 | 9.28 | 16.13 | 2.96 | 33.93 | 20.15 |
Dr. Reddy's Laboratories | 0.52 | 3.73 | -0.61 | 13.95 | -1.15 | 16.94 | 6.31 |
Mankind Pharma | -1.64 | 3.88 | 9.08 | 18.13 | 4.58 | 21.69 | 12.50 |
Zydus Lifesciences | -0.57 | 4.75 | 7.77 | 15.69 | -6.93 | 42.16 | 21.26 |
Lupin | 2.60 | 3.02 | 4.40 | 1.91 | -10.64 | 46.79 | 14.35 |
Abbott India | -0.85 | -4.90 | -2.43 | 2.84 | 7.47 | 21.30 | 13.54 |
Alkem Laboratories | 2.66 | 2.12 | 13.49 | 13.40 | -12.19 | 18.95 | 13.98 |
Aurobindo Pharma | 4.16 | 0.37 | -1.39 | -1.69 | -29.51 | 28.16 | 6.17 |
Glenmark Pharmaceuticals | -4.41 | 3.19 | 23.20 | 42.38 | 18.91 | 76.49 | 32.85 |
Anthem Biosciences | 5.89 | 7.84 | 18.23 | 18.23 | 18.23 | 5.74 | 3.41 |
Laurus Labs | -0.51 | 3.09 | 35.04 | 53.43 | 77.96 | 20.69 | 25.98 |
Biocon | -2.53 | -2.59 | 0.62 | 6.24 | -5.53 | 6.94 | -4.31 |
GlaxoSmithKline Pharmaceuticals | -3.46 | -1.94 | -15.89 | 1.60 | -2.30 | 24.69 | 9.19 |
Cohance Lifesciences | -2.30 | 7.56 | -2.57 | -14.86 | -16.33 | 28.11 | 20.30 |
Ipca Laboratories | -0.07 | -5.18 | -3.23 | -0.19 | -9.85 | 15.26 | 4.10 |
Gland Pharma | 4.39 | 0.78 | 13.75 | 27.92 | 7.57 | -3.99 | 1.77 |
Over the last one year, Everest Organics has gained 195.17% compared to peers like Sun Pharmaceutical Industries (-13.17%), Divi's Laboratories (11.03%), Cipla (-6.69%). From a 5 year perspective, Everest Organics has underperformed peers relative to Sun Pharmaceutical Industries (25.92%) and Divi's Laboratories (13.53%).
Day | SMA | EMA |
---|---|---|
5 | 413.01 | 417.39 |
10 | 401.62 | 409.43 |
20 | 400.12 | 396.47 |
50 | 358.48 | 376.48 |
100 | 377.78 | 357.55 |
200 | 314.01 | 315.58 |
In the latest quarter, Everest Organics saw a drop in promoter holding to 60.99%, while DII stake unchanged at 0.02%, FII holding unchanged at 0.00%, and public shareholding moved up to 38.99% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
---|---|
Sep 05, 2025, 9:32 PM IST | Everest Organics - Letter To Members |
Sep 04, 2025, 8:50 PM IST | Everest Organics - Reg. 34 (1) Annual Report. |
Sep 04, 2025, 8:31 PM IST | Everest Organics - 32Nd Annual General Meeting -Notice |
Aug 30, 2025, 4:29 PM IST | Everest Organics - General Updates-Newspaper Publication |
Aug 05, 2025, 9:39 PM IST | Everest Organics - Appointment of Company Secretary and Compliance Officer |
Everest Organics Ltd. is a Public Limited Listed company incorporated on 19/02/1993 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24230TG1993PLC015426 and registration number is 015426. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 159.48 Cr. and Equity Capital is Rs. 9.71 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Everest Organics is ₹412.50 as on Sep 17, 2025.
The Everest Organics is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Everest Organics is ₹400.56 Cr as on Sep 17, 2025.
Today’s highest and lowest price of Everest Organics are ₹429.00 and ₹412.50.
The 52-week high/low is the highest and lowest price at which Everest Organics stock has traded in the past 52-week or nearly a year. The 52-week high of Everest Organics is ₹477.00 and 52-week low of Everest Organics is ₹112.50 as on Sep 17, 2025.
The Everest Organics has shown returns of -1.93% over the past day, 12.6% for the past month, 13.01% over 3 months, 195.17% over 1 year, 42.24% across 3 years, and 8.12% over 5 years.
P/E ratio of and PB ratio of Everest Organics are 64.62 and 9.49 on Sep 17, 2025. While the company gives a dividend yield of 0.00 per annum.